Podcasts about future role

I am Rolf Claessen and together with my co-host Ken Suzan I am welcoming you to episode 169 of our podcast IP Fridays! Today's interview guest is Prof. Aloys Hüttermann, co-founder of my patent law firm Michalski Hüttermann & Partner and a true expert on the Unified Patent Court. He has written several books about the new system and we talk about all the things that plaintiffs and defendants can learn from the first decisions of the court and what they mean for strategic decisions of the parties involved. But before we jump into this very interesting interview, I have news for you! The US Patent and Trademark Office (USPTO) is planning rule changes that would make it virtually impossible for third parties to challenge invalid patents before the patent office. Criticism has come from the EFF and other inventor rights advocates: the new rules would play into the hands of so-called non-practicing entities (NPEs), as those attacked would have few cost-effective ways to have questionable patents deleted. The World Intellectual Property Organization (WIPO) reports a new record in international patent applications: in 2024, around 3.7 million patent applications were filed worldwide – an increase of 4.9% over the previous year. The main drivers were Asian countries (China alone accounted for 1.8 million), while demand for trademark protection has stabilized after the pandemic decline. US rapper Eminem is taking legal action in Australia against a company that sells swimwear under the name “Swim Shady.” He believes this infringes on his famous “Slim Shady” brand. The case illustrates that even humorous allusions to well-known brand names can lead to legal conflicts. A new ruling by the Unified Patent Court (UPC) demonstrates its cross-border impact. In “Fujifilm v. Kodak,” the local chamber in Mannheim issued an injunction that extends to the UK despite Brexit. The UPC confirmed its jurisdiction over the UK parts of a European patent, as the defendant Kodak is based in a UPC member state. A dispute over standard patents is looming at the EU level: the Legal Affairs Committee (JURI) of the European Parliament voted to take the European Commission to the European Court of Justice. The reason for this is the Commission’s controversial withdrawal of a draft regulation on the licensing of standard-essential patents (SEPs). Parliament President Roberta Metsola is to decide by mid-November whether to file the lawsuit. In trademark law, USPTO Director Squires reported on October 31, 2025, that a new unit (“Trademark Registration Protection Office”) had removed approximately 61,000 invalid trademark applications from the registries. This cleanup of the backlog relieved the examining authority and accelerated the processing of legitimate applications. Now let's jump into the interview with Aloys Hüttermann: The Unified Patent Court Comes of Age – Insights from Prof. Aloys Hüttermann The Unified Patent Court (UPC) has moved from a long-discussed project to a living, breathing court system that already shapes patent enforcement in Europe. In a recent IP Fridays interview, Prof. Aloys Hüttermann – founder and equity partner at Michalski · Hüttermann & Partner and one of the earliest commentators on the UPC – shared his experiences from the first years of practice, as well as his view on how the UPC fits into the global patent litigation landscape. This article summarises the key points of that conversation and is meant as an accessible overview for in-house counsel, patent attorneys and business leaders who want to understand what the UPC means for their strategy. How Prof. Hüttermann Became “Mr. UPC” Prof. Hüttermann has been closely involved with the UPC for more than a decade. When it became clear, around 13 years ago, that the European project of a unified patent court and a unitary patent was finally going to happen, he recognised that this would fundamentally change patent enforcement in Europe. He started to follow the legislative and political developments in detail and went beyond mere observation. As author and editor of several books and a major commentary on the UPC, he helped shape the discussion around the new system. His first book on the UPC appeared in 2016 – years before the court finally opened its doors in 2023. What fascinated him from the beginning was the unique opportunity to witness the creation of an entirely new court system, to analyse how it would be built and, where possible, to contribute to its understanding and development. It was clear to him that this system would be a “game changer” for European patent enforcement. UPC in the Global Triangle: Europe, the US and China In practice, most international patent disputes revolve around three major regions: the UPC territory in Europe, the United States and China. Each of these regions has its own procedural culture, cost structure and strategic impact. From a territorial perspective, the UPC is particularly attractive because it can, under the right conditions, grant pan-European injunctions that cover a broad range of EU Member States with a single decision. This consolidation of enforcement is something national courts in Europe simply cannot offer. From a cost perspective, the UPC is significantly cheaper than US litigation, especially if one compares the cost of one UPC action with a bundle of separate national cases in large European markets. When viewed against the territorial reach and procedural speed, the “bang for the buck” is very compelling. China is again a different story. The sheer volume of cases there is enormous, with tens of thousands of patent infringement cases per year. Chinese courts are known for their speed; first-instance decisions within about a year are common. In this respect they resemble the UPC more than the US does. The UPC also aims at a roughly 12 to 15 month time frame for first-instance cases where validity is at issue. The US, by contrast, features extensive discovery, occasionally jury trials and often longer timelines. The procedural culture is very different. The UPC, like Chinese courts, operates without discovery in the US sense, which makes proceedings more focused on the written record and expert evidence that the parties present, and less on pre-trial disclosure battles. Whether a company chooses to litigate in the US, the UPC, China, or some combination of these forums will depend on where the key markets and assets are. However, in Prof. Hüttermann's view, once Europe is an important market, it is hard to justify ignoring the UPC. He expects the court's caseload and influence to grow strongly over the coming years. A Landmark UPC Case: Syngenta v. Sumitomo A particularly important case in which Prof. Hüttermann was involved is the Syngenta v. Sumitomo matter, concerning a composition patent. This case has become a landmark in UPC practice for several reasons. First, the Court of Appeal clarified a central point about the reach of UPC injunctions. It made clear that once infringement is established in one Member State, this will usually be sufficient to justify a pan-European injunction covering all UPC countries designated by the patent. That confirmation gave patent owners confidence that the UPC can in fact deliver broad, cross-border relief in one go. Second, the facts of the case raised novel issues about evidence and territorial reach. The allegedly infringing product had been analysed based on a sample from the Czech Republic, which is not part of the UPC system. Later, the same product with the same name was marketed in Bulgaria, which is within UPC territory. The Court of Appeal held that the earlier analysis of the Czech sample could be relied on for enforcement in Bulgaria. This showed that evidence from outside the UPC territory can be sufficient, as long as it is properly linked to the products marketed within the UPC. Third, the Court of Appeal took the opportunity to state its view on inventive step. It confirmed that combining prior-art documents requires a “pointer”, in line with the EPO's problem-solution approach. The mere theoretical possibility of extracting a certain piece of information from a document does not suffice to justify an inventive-step attack. This is one of several decisions where the UPC has shown a strong alignment with EPO case law on substantive patentability. For Prof. Hüttermann personally, the case was also a lesson in oral advocacy before the UPC. During the two appeal hearings, the presiding judge asked unexpected questions that required quick and creative responses while the hearing continued. His practical takeaway is that parties should appear with a small, well-coordinated team: large enough to allow someone to work on a tricky question in the background, but small enough to remain agile. Two or three lawyers seem ideal; beyond that, coordination becomes difficult and “too many cooks spoil the broth”. A Game-Changing CJEU Decision: Bosch Siemens Hausgeräte v. Electrolux Surprisingly, one of the most important developments for European patent litigation in the past year did not come from the UPC at all, but from the Court of Justice of the European Union. In Bosch Siemens Hausgeräte v. Electrolux, the CJEU revisited the rules on cross-border jurisdiction under the Brussels I Recast Regulation (Brussels Ia). Previously, under what practitioners often referred to as the GAT/LuK regime, a court in one EU country was largely prevented from granting relief for alleged infringement in another country if the validity of the foreign patent was contested there. This significantly limited the possibilities for cross-border injunctions. In Bosch, the CJEU changed course. Without going into all procedural details, the essence is that courts in the EU now have broader powers to grant cross-border relief when certain conditions are met, particularly when at least one defendant is domiciled in the forum state. The concept of an “anchor defendant” plays a central role: if you sue one group company in its home forum, other group companies in other countries, including outside the EU, can be drawn into the case. This has already had practical consequences. German courts, for example, have issued pan-European injunctions covering around twenty countries in pharmaceutical cases. There are even attempts to sue European companies for infringement of US patents based on acts in the US, using the logic of Bosch as a starting point. How far courts will ultimately go remains to be seen, but the potential is enormous. For the UPC, this development is highly relevant. The UPC operates in the same jurisdictional environment as national courts, and many defendants in UPC cases will be domiciled in UPC countries. This increases the likelihood that the UPC, too, can leverage the broadened possibilities for cross-border relief. In addition, we have already seen UPC decisions that include non-EU countries such as the UK within the scope of injunctions, in certain constellations. The interaction between UPC practice and the Bosch jurisprudence of the CJEU is only beginning to unfold. Does the UPC Follow EPO Case Law? A key concern for many patent owners and practitioners is whether the UPC will follow the EPO's Boards of Appeal or develop its own, possibly divergent, case law on validity. On procedural matters, the UPC is naturally different from the EPO. It has its own rules of procedure, its own timelines and its own tools, such as “front-loaded” pleadings and tight limits on late-filed material. On substantive law, however, Prof. Hüttermann's conclusion is clear: there is “nothing new under the sun”. The UPC's approach to novelty, inventive step and added matter is very close to that of the EPO. The famous “gold standard” for added matter appears frequently in UPC decisions. Intermediate generalisations are treated with the same suspicion as at the EPO. In at least one case, the UPC revoked a patent for added matter even though the EPO had granted it in exactly that form. The alignment is not accidental. The UPC only deals with European patents granted by the EPO; it does not hear cases on purely national patents. If the UPC were more generous than the EPO, many patents would never reach it. If it were systematically stricter, patentees would be more tempted to opt out of the system. In practice, the UPC tends to apply the EPO's standards and, where anything differs, it is usually a matter of factual appreciation rather than a different legal test. For practitioners, this has a very practical implication: if you want to predict how the UPC will decide on validity, the best starting point is to ask how the EPO would analyse the case. The UPC may not always reach the same result in parallel EPO opposition proceedings, but the conceptual framework is largely the same. Trends in UPC Practice: PIs, Equivalents and Division-Specific Styles Even in its early years, certain trends and differences between UPC divisions can be observed. On preliminary injunctions, the local division in Düsseldorf has taken a particularly proactive role. It has been responsible for most of the ex parte PIs granted so far and applies a rather strict notion of urgency, often considering one month after knowledge of the infringement as still acceptable, but treating longer delays with scepticism. Other divisions tend to see two months as still compatible with urgency, and they are much more cautious with ex parte measures. Munich, by contrast, has indicated a strong preference for inter partes PI proceedings and appears reluctant to grant ex parte relief at all. A judge from Munich has even described the main action as the “fast” procedure and the inter partes PI as the “very fast” one, leaving little room for an even faster ex parte track. There are also differences in how divisions handle amendments and auxiliary requests in PI proceedings. Munich has suggested that if a patentee needs to rely on claim amendments or auxiliary requests in a PI, the request is unlikely to succeed. Other divisions have been more open to considering auxiliary requests. The doctrine of equivalents is another area where practice is not yet harmonised. The Hague division has explicitly applied a test taken from Dutch law in at least one case and found infringement by equivalence. However, the Court of Appeal has not yet endorsed a specific test, and in another recent Hague case the same division did not apply that Dutch-law test again. The Mannheim division has openly called for the development of an autonomous, pan-European equivalence test, but has not yet fixed such a test in a concrete decision. This is clearly an area to watch. Interim conferences are commonly used in most divisions to clarify issues early on, but Düsseldorf often dispenses with them to save time. In practice, interim conferences can be very helpful for narrowing down the issues, though parties should not expect to be able to predict the final decision from what is discussed there. Sometimes topics that dominate the interim conference play little or no role in the main oral hearing. A Front-Loaded System and Typical Strategic Mistakes UPC proceedings are highly front-loaded and very fast. A defendant usually has three months from service of the statement of claim to file a full statement of defence and any counterclaim for revocation. This is manageable, but only if the time is used wisely. One common strategic problem is that parties lose time at the beginning and only develop a clear strategy late in the three-month period. According to Prof. Hüttermann, it is crucial to have a firm strategy within the first two or three weeks and then execute it consistently. Constantly changing direction is a recipe for failure in such a compressed system. Another characteristic is the strict attitude towards late-filed material. It is difficult to introduce new documents or new inventive-step attacks later in the procedure. In some cases even alternative combinations of already-filed prior-art documents have been viewed as “new” attacks and rejected as late. At the appeal stage, the Court of Appeal has even considered new arguments based on different parts of a book already in the file as potentially late-filed. This does not mean that parties should flood the court with dozens of alternative attacks in the initial brief. In one revocation action, a plaintiff filed about fifty different inventive-step attacks, only to be told by the court that this was not acceptable and that the attacks had to be reduced and structured. The UPC is not a body conducting ex officio examination. It is entitled to manage the case actively and to ask parties to focus on the most relevant issues. Evidence Gathering, Protective Letters and the Defendant's Perspective The UPC provides powerful tools for both sides. Evidence inspection is becoming more common, not only at trade fairs but also at company premises. This can be a valuable tool for patentees, but it also poses a serious risk for defendants who may suddenly face court-ordered inspections. From the perspective of potential defendants, protective letters are an important instrument, especially in divisions like Düsseldorf where ex parte PIs are possible. A well-written protective letter, filed in advance, can significantly reduce the risk of a surprise injunction. The court fees are moderate, but the content of the protective letter must be carefully prepared; a poor submission can cause more harm than good. Despite the strong tools available to patentees, Prof. Hüttermann does not view the UPC as unfair to defendants. If a defendant files a solid revocation counterclaim, the pressure shifts to the patentee, who then has only two months to reply, prepare all auxiliary requests and adapt the enforcement strategy. This is even more demanding than at the EPO, because the patentee must not only respond to validity attacks but also ensure that any amended claims still capture the allegedly infringing product. It is entirely possible to secure the survival of a patent with an auxiliary request that no longer covers the defendant's product. In that scenario, the patentee has “won” on validity but lost the infringement case. Managing this tension under tight time limits is a key challenge of UPC practice. The Future Role of the UPC and How to Prepare Today the UPC hears a few hundred cases per year, compared with several thousand patent cases in the US and tens of thousands in China. Nevertheless, both the court itself and experienced practitioners see significant growth potential. Prof. Hüttermann expects case numbers to multiply in the medium term. Whether the UPC will become the first choice forum in global disputes or remain one pillar in parallel proceedings alongside the US and China will depend on the strategies of large patentees and the evolution of case law. However, the court is well equipped: it covers a large, economically important territory, is comparatively cost-effective and offers fast procedures with robust remedies. For companies that may end up before the UPC, preparation is essential. On the offensive side, that means building strong evidence and legal arguments before filing, being ready to proceed quickly and structured, and understanding the specific styles of the relevant divisions. On the defensive side, it may mean filing protective letters in risk-exposed markets, preparing internal processes for rapid reaction if a statement of claim arrives, and taking inspection requests seriously. Conclusion The Unified Patent Court has quickly moved from theory to practice. It offers pan-European relief, fast and front-loaded procedures, and a substantive approach that closely mirrors the EPO's case law. At the same time, national and EU-level developments like the Bosch Siemens Hausgeräte v. Electrolux decision are reshaping the jurisdictional framework in which the UPC operates, opening the door for far-reaching cross-border injunctions. For patent owners and potential defendants alike, the message is clear: the UPC is here to stay and will become more important year by year. Those who invest the time to understand its dynamics now – including its alignment with the EPO, the differences between divisions, and the strategic implications of its procedures – will be in a much better position when the first UPC dispute lands on their desk. Here is the full transcript of the interview: Rolf Claessen:Today's interview guest is Prof. Aloys Hüttermann. He is founder and equity partner of my firm, Michalski · Hüttermann & Partner. More importantly for today's interview, he has written several books about the Unified Patent Court. The first one already came out in 2016. He is co-editor and author of one of the leading commentaries on the UPC and has gained substantial experience in UPC cases so far – one of them even together with me. Thank you very much for being on IP Fridays again, Aloys. Aloys Hüttermann:Thank you for inviting me, it's an honour. How did you get so deeply involved in the UPC? Rolf Claessen:Before we dive into the details, how did you end up so deeply involved in the Unified Patent Court? And what personally fascinates you about this court? Aloys Hüttermann:This goes back quite a while – roughly 13 years. At that time it became clear that, after several failed attempts, Europe would really get a pan-European court and a pan-European patent, and that this time it was serious. I thought: this is going to be the future. That interested me a lot, both intellectually and practically. A completely new system was being built. You could watch how it evolved – and, if possible, even help shape it a bit. It was also obvious to me that this would be a complete game changer. Nobody expected that it would take until 2023 before the system actually started operating, but now it is here. I became heavily interested early on. As you mentioned, my first book on the UPC was published in 2016, in the expectation that the system would start soon. It took a bit longer, but now we finally have it. UPC vs. US and China – speed, cost and impact Rolf Claessen:Before we go deeper into the UPC, let's zoom out. If you compare litigation before the UPC with patent litigation in the US and in China – in terms of speed, cost and the impact of decisions – what are the key differences that a business leader should understand? Aloys Hüttermann:If you look at the three big regions – the UPC territory in Europe, the US and China – these are the major economic areas for many technology companies. One important point is territorial reach. In the UPC, if the conditions are met, you can get pan-European injunctions that cover many EU Member States in one go. We will talk about this later in more detail. On costs there is a huge difference between the US and the UPC. The UPC is much cheaper than US litigation, especially once you look at the number of countries you can cover with one case if the patent has been validated widely. China is different again. The number of patent infringement cases there is enormous. I have seen statistics of around 40,000 infringement cases per year in China. That is huge – compared with roughly 164 UPC infringement cases in the first year and maybe around 200 in the current year. On speed, Chinese courts are known to be very fast. You often get a first-instance decision in about a year. The UPC is comparable: if there is a counterclaim for revocation, you are looking at something like 12 to 15 months for a first-instance decision. The US can be slower, and the procedure is very different. You have full discovery, you may have juries. None of that exists at the UPC. From that perspective, Chinese and UPC proceedings are more similar to each other than either is to the US. The UPC is still a young court. We have to see how influential its case law will be worldwide in the long run. What we already see, at least in Germany, is a clear trend away from purely national patent litigation and towards the UPC. That is inside Europe. The global impact will develop over time. When is the UPC the most powerful tool? Rolf Claessen:Let's take the perspective of a global company. It has significant sales in Europe and in the US and production or key suppliers in China. In which situations would you say the UPC is your most powerful tool? And when might the US or China be the more strategic battleground? Aloys Hüttermann:To be honest, I would almost always consider bringing a case before the UPC. The “bang for the buck” is very good. The UPC is rather fast. That alone already gives you leverage in negotiations. The threat of a quick, wide-reaching injunction is a strong negotiation tool. Whether you litigate in the US instead of the UPC, or in addition, or whether you also go to China – that depends heavily on the individual case: where the products are sold, where the key markets are, where the defendant has assets, and so on. But in my view, once you have substantial sales in Europe, you should seriously consider the UPC. And for that reason alone I expect case numbers at the UPC to increase significantly in the coming years. A landmark UPC case: Syngenta vs. Sumitomo (composition patent) Rolf Claessen:You have already been involved in several UPC cases – and one of them together with me, which was great fun. Looking at the last 12 to 18 months, is there a case, decision or development that you find particularly noteworthy – something that really changed how you think about UPC litigation or how companies should prepare? Aloys Hüttermann:The most important UPC case I have been involved in so far is the Syngenta v. Sumitomo case on a composition patent. It has become a real landmark and was even mentioned in the UPC's annual report. It is important for several reasons. First, it was one of the first cases in which the Court of Appeal said very clearly: if you have established infringement in one Member State, that will usually be enough for a pan-European injunction covering all UPC countries designated by the patent. That is a powerful statement about the reach of UPC relief. Second, the facts were interesting. The patent concerned a composition. We had analysed a sample that had been obtained in the Czech Republic, which is not a UPC country. Later, the same product was marketed under the same name in Bulgaria, which is in the UPC. The question was whether the analysis of the Czech sample could be used as a basis for enforcement in Bulgaria. The Court of Appeal said yes, that was sufficient. Third, the Court of Appeal took the opportunity to say something about inventive step. It more or less confirmed that the UPC's approach is very close to the EPO's problem-solution approach. It emphasised that, if you want to combine prior-art documents, you need a “pointer” to do so. The mere theoretical possibility that a skilled person could dig a particular piece of information out of a document is not enough. For me personally, the most memorable aspect of this case was not the outcome – that was largely in line with what we had expected – but the oral hearings at the appeal stage. We had two hearings. In both, the presiding judge asked us a question that we had not anticipated at all. And then you have about 20 minutes to come up with a convincing answer while the hearing continues. We managed it, but it made me think a lot about how you should prepare for oral hearings at the UPC. My conclusion is: you should go in with a team, but not too big. In German we say, “Zu viele Köche verderben den Brei” – too many cooks spoil the broth. Two or three people seems ideal. One of them can work quietly on such a surprise question at the side, while the others continue arguing the case. In the end the case went very well for us, so I can speak about it quite calmly now. But in the moment your heart rate definitely goes up. The CJEU's Bosch Siemens Hausgeräte v. Electrolux decision – a real game changer Rolf Claessen:You also mentioned another development that is not even a UPC case, but still very important for European patent litigation. Aloys Hüttermann:Yes. In my view, the most important case of the last twelve months is not a UPC decision but a judgment of the Court of Justice of the EU (CJEU): Bosch Siemens Hausgeräte v. Electrolux. This is going to be a real game changer for European IP law, and I am sure we have not seen the end of its effects yet. One example: someone has recently sued BMW before the Landgericht München I, a German court, for infringement of a US patent based on acts in the US. The argument is that this could be backed by the logic of Bosch Siemens Hausgeräte v. Electrolux. We do not know yet what the court will do with that, but the fact that people are trying this shows how far-reaching the decision might be. Within the UPC we have already seen injunctions being issued for countries outside the UPC territory and even outside the EU, for example including the UK. So you see how these developments start to interact. Rolf Claessen:For listeners who have not followed the case so closely: in very simple terms, the CJEU opened the door for courts in one EU country to rule on patent infringement that took place in other countries as well, right? Aloys Hüttermann:Exactly. Before Bosch Siemens Hausgeräte v. Electrolux we had what was often called the GAT/LuK regime. The basic idea was: if you sue someone in, say, Germany for infringement of a European patent, and you also ask for an injunction for France, and the defendant then challenges the validity of the patent in France, the German court cannot grant you an injunction covering France. The Bosch decision changed that. The legal basis is the Brussels I Recast Regulation (Brussels Ia), which deals with jurisdiction in civil and commercial matters in the EU. It is not specific to IP; it applies to civil cases generally, but it does have some provisions that are relevant for patents. In Bosch, a Swedish court asked the CJEU for guidance on cross-border injunctions. The CJEU more or less overturned its old GAT/LuK case law. Now, in principle, if the defendant is domiciled in a particular Member State, the courts of that state can also grant cross-border relief for other countries, under certain conditions. We will not go into all the details here – that could fill a whole separate IP Fridays episode – but one important concept is the “anchor defendant”. If you sue a group of companies and at least one defendant is domiciled in the forum state, then other group companies in other countries – even outside the EU, for example in Hong Kong – can be drawn into the case and affected by the decision. This is not limited to the UPC, but of course it is highly relevant for UPC litigation. Statistically it increases the chances that at least one defendant will be domiciled in a UPC country, simply because there are many of them. And we have already seen courts like the Landgericht München I grant pan-European injunctions for around 20 countries in a pharmaceutical case. Rolf Claessen:Just to clarify: does it have to be the headquarters of the defendant in that country, or is any registered office enough? Aloys Hüttermann:That is one of the open points. If the headquarters are in Europe, then it is clear that subsidiaries outside Europe can be affected as well. If the group's headquarters are outside Europe and only a subsidiary is here, the situation is less clear and we will have to see what the courts make of it. Does the UPC follow EPO case law? Rolf Claessen:Many patent owners and in-house counsel wonder: does the UPC largely follow the case law of the EPO Boards of Appeal, or is it starting to develop its own distinct line? What is your impression so far – both on substantive issues like novelty and inventive step, and on procedural questions? Aloys Hüttermann:On procedure the UPC is, of course, very different. It has its own procedural rules and they are not the same as at the EPO. If we look at patent validity, however, my impression is that there is “nothing new under the sun” – that was the title of a recent talk I gave and will give again in Hamburg. Substantively, the case law of the UPC and the EPO is very similar. For inventive step, people sometimes say the UPC does not use the classical problem-solution approach but a more “holistic” approach – whatever that is supposed to mean. In practice, in both systems you read and interpret prior-art documents and decide what they really disclose. In my view, the “error bar” that comes from two courts simply reading a document slightly differently is much larger than any systematic difference in legal approach. If you look at other grounds, such as novelty and added matter, the UPC even follows the EPO almost verbatim. The famous “gold standard” for added matter appears all over UPC decisions, even if the EPO case numbers are not always cited. The same is true for novelty. So the rule-based, almost “Hilbertian” EPO approach is very much present at the UPC. There is also a structural reason for that. All patents that the UPC currently deals with have been granted by the EPO. The UPC does not handle patents granted only by national offices. If the UPC wanted to deviate from EPO case law and be more generous, then many patents would never reach the UPC in the first place. The most generous approach you can have is the one used by the granting authority – the EPO. So if the UPC wants to be different, it can only be stricter, not more lenient. And there is little incentive to be systematically stricter, because that would reduce the number of patents that are attractive to enforce before the UPC. Patent owners might simply opt out. Rolf Claessen:We also talked about added matter and a recent case where the Court of Appeal was even stricter than the EPO. That probably gives US patent practitioners a massive headache. They already struggle with added-matter rules in Europe, and now the UPC might be even tougher. Aloys Hüttermann:Yes, especially on added matter. I once spoke with a US practitioner who said, “We hope the UPC will move away from intermediate generalisations.” There is no chance of that. We already have cases where the Court of Appeal confirmed that intermediate generalisations are not allowed, in full alignment with the EPO. You mentioned a recent case where a patent was revoked for added matter, even though it had been granted by the EPO in exactly that form. This shows quite nicely what to expect. If you want to predict how the UPC will handle a revocation action, the best starting point is to ask: “What would the EPO do?” Of course, there will still be cases where the UPC finds an invention to be inventive while the EPO, in parallel opposition proceedings, does not – or vice versa. But those are differences in the appreciation of the facts and the prior art, which you will always have. The underlying legal approach is essentially the same. Rolf Claessen:So you do not see a real example yet where the UPC has taken a totally different route from the EPO on validity? Aloys Hüttermann:No, not really. If I had to estimate how the UPC will decide, I would always start from what I think the EPO would have done. Trends in UPC practice: PIs, equivalents, interim conferences Rolf Claessen:If you look across the different UPC divisions and cases: what trends do you see in practice? For example regarding timelines, preliminary injunctions, how validity attacks are handled, and how UPC cases interact with EPO oppositions or national proceedings? Aloys Hüttermann:If you take the most active divisions – essentially the big four in Germany and the local division in The Hague – they all try to be very careful and diligent in their decisions. But you can already see some differences in practice. For preliminary injunctions there is a clear distinction between the local division in Düsseldorf and most other divisions. Düsseldorf considers one month after knowledge of the infringement as still sufficiently urgent. If you wait longer, it is usually considered too late. In many other divisions, two months is still viewed as fine. Düsseldorf has also been the division that issued most of the ex parte preliminary injunctions so far. Apart from one special outlier where a standing judge from Brussels was temporarily sitting in Milan, Düsseldorf is basically the only one. Other divisions have been much more reluctant. At a conference, Judge Pichlmaier from the Munich division once said that he could hardly imagine a situation where his division would grant an ex parte PI. In his words, the UPC has two types of procedure: one that is fast – the normal main action – and one that is very fast – the inter partes PI procedure. But you do not really have an “ultra-fast” ex parte track, at least not in his division. Another difference relates to amendments and auxiliary requests in PI proceedings. In one recent case in Munich the court said more or less that if you have to amend your patent or rely on auxiliary requests in a PI, you lose. Other divisions have been more flexible and have allowed auxiliary requests. Equivalence is another area where we do not have a unified line yet. So far, only the Hague division has clearly found infringement under the doctrine of equivalents and explicitly used a test taken from Dutch law. Whether that test will be approved by the Court of Appeal is completely open – the first case settled, so the Court of Appeal never ruled on it, and a second one is still very recent. Interestingly, there was another Hague decision a few weeks ago where equivalence was on the table, but the division did not apply that Dutch-law test. We do not know yet why. The Mannheim division has written in one decision that it would be desirable to develop an autonomous pan-European test for equivalence, instead of just importing the German, UK or Dutch criteria. But they did not formulate such a test in that case because it was not necessary for the decision. So we will have to see how that evolves. On timelines, one practical difference is that Düsseldorf usually does not hold an interim conference. That saves them some time. Most other divisions do hold interim conferences. Personally, I like the idea because it can help clarify issues. But you cannot safely read the final outcome from these conferences. I have also seen cases where questions raised at the interim conference did not play any role in the main oral hearing. So they are useful for clarification, but not as a crystal ball. Front-loaded proceedings and typical strategic mistakes Rolf Claessen:If you look at the behaviour of parties so far – both patentees and defendants – what are the most common strategic mistakes you see in UPC litigation? And what would a well-prepared company do differently before the first statement of claim is ever filed? Aloys Hüttermann:You know you do not really want me to answer that question… Rolf Claessen:I do! Aloys Hüttermann:All right. The biggest mistake, of course, is that they do not hire me. That is the main problem. Seriously, it is difficult to judge parties' behaviour from the outside. You rarely know the full picture. There may be national proceedings, licensing discussions, settlement talks, and so on in the background. That can limit what a party can do at the UPC. So instead of criticising, I prefer to say what is a good idea at the UPC. The system is very front-loaded and very fast. If you are sued, you have three months to file your statement of defence and your counterclaim for revocation. In my view, three months are manageable – but only if you use the time wisely and do not waste it on things that are not essential. If you receive a statement of claim, you have to act immediately. You should have a clear strategy within maybe two or three weeks and then implement it. If you change your strategy every few weeks, chances are high that you will fail. Another point is that everything is front-loaded. It is very hard to introduce new documents or new attacks later. Some divisions have been a bit generous in individual cases, but the general line is strict. We have seen, for example, that even if you filed a book in first instance, you may not be allowed to rely on a different chapter from the same book for a new inventive-step attack at the appeal stage. That can be regarded as late-filed, because you could have done it earlier. There is also case law saying that if you first argue inventive step as “D1 plus D2”, and later want to argue “D2 plus D1”, that can already be considered a new, late attack. On the other hand, we had a revocation action where the plaintiff filed about 50 different inventive-step attacks in the initial brief. The division then said: this does not work. Please cut them down or put them in a clear hierarchy. In the end, not all of them were considered. The UPC does not conduct an ex officio examination. It is entitled to manage the case and to tell the parties to limit themselves in the interest of a fair and efficient procedure. Rolf Claessen:I have the feeling that the EPO is also becoming more front-loaded – if you want to rely on documents later, you should file them early. But it sounds like the UPC is even more extreme in that regard. Aloys Hüttermann:Yes, that is true. Protective letters, inspections and the defendant's perspective Rolf Claessen:Suppose someone from a company is listening now and thinks: “We might be exposed at the UPC,” or, “We should maybe use the UPC offensively against competitors.” What would you consider sensible first steps before any concrete dispute arises? And looking three to five years ahead, how central do you expect the UPC to become in global patent litigation compared to the US and China? Aloys Hüttermann:Let me start with the second part. I expect the UPC to become significantly more important. If we have around 200 cases this year, that is a good start, but it is still very small compared to, say, 4,000 to 5,000 patent cases per year in the US and 40,000 or so in China. Even François Bürgin and Klaus Grabinski, in interviews, have said that they are happy with the case load, but the potential is much larger. In my view, it is almost inevitable that we will see four or five times as many UPC cases in the not-too-distant future. As numbers grow, the influence of the UPC will grow as well. Whether, in five or ten years, companies will treat the UPC as their first choice forum – or whether they will usually run it in parallel with US litigation in major disputes – remains to be seen. The UPC would be well equipped for that: the territory it covers is large, Europe is still an important economy, and the UPC procedure is very attractive from a company's perspective. On sensible first steps: if you are worried about being sued, a protective letter can make a lot of sense – especially in divisions like Düsseldorf, where ex parte PIs are possible in principle. A protective letter is not very expensive in terms of court fees. There is also an internal system that ensures the court reads it before deciding on urgent measures. Of course, the content must have a certain quality; a poor protective letter can even backfire. If you are planning to sue someone before the UPC, you should be extremely well prepared when you file. You should already have all important documents and evidence at hand. As we discussed, it is hard to introduce new material later. One tool that is becoming more and more popular is inspection – not just at trade fairs, where we already saw cases very early, but also at company premises. Our firm has already handled such an inspection case. That is something you should keep in mind on both sides: it is a powerful evidence-gathering tool, but also a serious risk if you are on the receiving end. From the defendant's perspective, I do not think the UPC is unfair. If you do your job properly and put a solid revocation counterclaim on the table, then the patentee has only two months to prepare a full reply and all auxiliary requests. And there is a twist that makes life even harder for the patentee than at the EPO. At the EPO the question is mainly: do my auxiliary requests overcome the objections and are they patentable? At the UPC there is an additional layer: do I still have infringement under the amended claims? You may save your patent with an auxiliary request that no longer reads on the defendant's product. That is great for validity, but you have just lost the infringement case. You have kept the patent but lost the battle. And all of this under very tight time limits. That creates considerable pressure on both sides. How to contact Prof. Hüttermann Rolf Claessen:Thank you very much for this really great interview, Aloys. Inside our firm you have a nickname: “the walking encyclopedia of the Unified Patent Court” – because you have written so many books about it and have dealt with the UPC for such a long time. What is the best way for listeners to get in touch with you? Aloys Hüttermann:The easiest way is by email. You can simply write to me, and that is usually the best way to contact me. As you may have noticed, I also like to speak. I am a frequent speaker at conferences. If you happen to be at one of the conferences where I am on the programme – for example, next week in Hamburg – feel free to come up to me and ask me anything in person. But email is probably the most reliable first step. Rolf Claessen:Perfect. Thank you very much, Aloys. Aloys Hüttermann:Thank you. It was a pleasure to be on IP Fridays again. Some of your long-time listeners may remember that a few years ago – when you were not yet part of our firm – we already did an episode on the UPC, back when everything was still very speculative. It is great to be back now that the system is actually in place and working. Rolf Claessen:I am very happy to have you back on the show.

Featuring slide presentations and related discussion from Prof Francois-Clement Bidard, Dr Hope S Rugo, Dr Rebecca Shatsky and Dr Seth Wander, including the following topics: Optimal approach to biomarker testing for patients with ER-positive metastatic breast cancer (mBC) (0:00) Case: A woman in her early 70s with recurrent ER-positive, HER2-negative mBC receives elacestrant (15:15) Case: A woman in her early 60s with ER-positive, HER2-low, PIK3CA-mutated mBC receives inavolisib-based therapy and experiences no disease progression for 24 months (18:02) Role of oral selective estrogen receptor degrader (SERD) monotherapy in the treatment of progressive ER-positive, HER2-negative mBC (26:26) Case: A woman in her mid 60s with recurrent HR-positive, HER2-negative mBC receives elacestrant (44:12) Case: A woman in her early 50s with recurrent HR-positive, HER2-negative, PIK3CA-mutant mBC receives capivasertib and fulvestrant (45:33) Potential novel applications of oral SERDs in the management of ER-positive, HER2-negative breast cancer (51:25) Case: A woman in her mid 50s with recurrent ER-positive, HER2-negative, PIK3CA-mutated mBC experiences disease progression 18 months after starting first-line letrozole and ribociclib (1:03:46) Case: A woman in her mid 50s with ER-positive, HER2-negative breast cancer undergoes serial ctDNA monitoring during first-line therapy (1:06:54) Tolerability and other practical considerations with oral SERDs (1:14:30) Case: A woman in her early 60s with recurrent HR-positive, HER2-negative mBC receives elacestrant (1:33:26) Case: A woman in her early 60s with recurrent HR-positive, HER2-negative mBC receives elacestrant (1:37:38) CME information and select publications

Prof Francois-Clement Bidard from the Institut Curie in Paris, France, Dr Hope S Rugo from the City of Hope Comprehensive Cancer Center in Duarte, California, Dr Rebecca Shatsky from the University of California San Diego Moores Cancer Center and Dr Seth Wander from Massachusetts General Hospital in Boston discuss recent updates on available and emerging treatment strategies involving oral SERDs for ER-positive metastatic breast cancer. CME information and select publications here.

Featuring perspectives from Dr Emmanuel S Antonarakis and Dr Matthew R Smith, including the following topics:  Current and Future Role of Immune Checkpoint Inhibitors in the Management of Colorectal Cancer — Dr Lieu (0:00) Other Biomarker-Based Strategies for Patients with Colorectal Cancer — Dr Strickler (36:39) CE information and select publications

In this episode, I explore the paradox of Artificial Intelligence, not as a hero or a villain, but as a mirror. What's really rising or falling isn't AI itself—it's us, the humans holding the prompt. Together, GPT-5 and I unpack how this technology can awaken creativity or quietly erode it, depending on how consciously we engage with it. Make Sense? What you're about to hear is not just a conversation between man and machine. It's a collaboration between awareness and automation, a real-time experiment in creation itself. Because here's the question that keeps me up at night: What happens when the tools we built to extend human intelligence start to replace the act of thinking itself? This episode isn't about whether AI is good or bad. It's about whether we, as humans, will rise with it—or fall asleep beneath it. So, take a breath. Let's make sense… of the Rise and Fall of AI. Follow Dr. JC Doornick and the Makes Sense Academy: ► Makes Sense Substack - https://drjcdoornick.substack.com ► Instagram: / drjcdoornick ►Facebook:  / makessensepodcast ►YouTube:  / drjcdoornick MAKES SENSE PODCAST Welcome to the Makes Sense with Dr. JC Doornick Podcast. This podcast explores topics that expand human consciousness and enhance performance. On the Makes Sense Podcast, we acknowledge that it's who you are that determines how well what you do works, and that perception is a subjective and acquired taste. When you change the way you look at things, the things you look at begin to change. Welcome to the uprising of the sleepwalking masses. Welcome to the Makes Sense with Dr. JC Doornick Podcast. SUBSCRIBE/RATE/REVIEW & SHARE our new podcast. FOLLOW Podcast - You will find a "Follow" button on the top right. This will enable the podcast software to alert you when a new episode launches each week. Apple: https://podcasts.apple.com/ca/podcast/makes-sense-with-dr-jc-doornick/id1730954168 Spotify: https://open.spotify.com/show/1WHfKWDDReMtrGFz4kkZs9?si=003780ca147c4aec Podcast Affiliates: Kwik Learning: Many people ask me where I get all these topics, which I've been covering for almost 15 years. I have learned to read nearly four times faster and retain information 10 times better with Kwik Learning. Learn how to learn and earn with Jim Kwik. Get his program at a special discount here: https://jimkwik.com/dragon OUR SPONSORS: Makes Sense Academy: A private mastermind and psychologically safe environment full of the Mindset and Action steps that will help you begin to thrive. The Makes Sense Academy. https://www.skool.com/makes-sense-academy/about The Sati Experience: A retreat designed for the married couple that truly loves one another, yet wants to take their love to that higher magical level. Relax, reestablish, and renew your love at the Sati Experience. https://www.satiexperience.com Highlights: 0:00 - Intro 4:15 - In this episode, we will…. 8:37 - Opening Remarks from ChatGPT 16:44 - The Rise Of AI 22:21 - AI as a Luxury to Necessity 25:32 - Collaboration 27:35 - The Fall of Ai? 31:48 - The Learning Dilemma  37:03 - The Future Role of Humans? 40:12 - The Final Verdict from Chat GPT Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Dr. Jones sits down with Eric Stoffers, CEO and founder of BioXcellerator, a global leader in stem cell therapy and regenerative medicine. Stoffers is an international pioneer in health, immunity, and longevity, with a vision to make advanced therapies more accessible for patients with autoimmune, orthopedic, neurological, and degenerative conditions.From his work at BioXcellerator to his leadership as Chairman of Solutions for a Healthier World, a nonprofit focused on improving lives through medicine, science, and education, Stoffers brings innovation and compassion to the future of healthcare.Listeners will hear insights on the science behind stem cells, detailing the differences between various sources like adipose tissue, bone marrow, and umbilical cords. They explore the unique properties of mesenchymal stem cells (MSCs), contrasting them with exosomes and addressing common industry myths, including the use of embryonic cells.You'll hear about the conditions showing the most promising results, from orthopedic and autoimmune issues to neurological injuries like TBIs and spinal cord damage. Eric also discusses the regulatory landscape that differentiates treatment in the U.S. from options abroad, the patient experience at his clinic in Medellin, Colombia, and why he believes regenerative medicine is the present, not the future.

J.D. Greear and Joel Rosenberg on Revelation and the Church/Inside the Epicenter Explores Biblical Promises and Modern Realities/Replacement Theology, Israel, and the ChurchWelcome to Inside the Epicenter! In this episode, host Joel Rosenberg welcomes J.D. Greear, influential pastor and former Southern Baptist Convention president, to discuss whether God is finished with Israel and what that means for the church today. Together, they dive into the theological debate around replacement theology and explore how the Bible points to a future for ethnic Israel, especially through the lens of Revelation. J.D. shares his approach to teaching prophecy and the importance of loving both Israel and her neighbors, including Muslims, while Joel presses on how these beliefs shape ministry, missions, and compassion in a time of conflict. With practical insights for pastors, young evangelicals, and anyone wrestling with these big questions, this episode sheds fresh light on prophecy, mission, and the church’s role in blessing the Epicenter. Stay tuned for engaging perspectives and stories you won’t want to miss! (00:02) "Educating Christians to Bless Israel"(05:35) "JD's Winsome Scriptural Approach"(11:35) Israel, Church, and Biblical Covenants(17:00) "Unashamed Gospel and Jewish Focus"(22:50) Future Role of Ethnic Israel(29:41) Biblical Perspective on Critical Theory(32:17) "Being Beloved in Community"(37:35) Blessings, Israel, and Politics(46:16) "Expanding God's Work in Media"(51:19) Literal vs. Metaphorical Revelation Interpretation(54:17) Young Pastor's Biblical View on Israel(59:28) "Growing Ministry, Blessing the Church"(01:07:11) "Subscribe and Share Podcast" Learn more about The Joshua Fund: JoshuaFund.comMake a tax-deductible donation: Donate | The Joshua FundStock Media provided by DimmySad / Pond5 Verse of the Day: Genesis 12:1-3 - Now the Lord said to Abram, “Go from your country and your kindred and your father’s house to the land that I will show you. And I will make of you a great nation, and I will bless you and make your name great, so that you will be a blessing. I will bless those who bless you, and him who dishonors you I will curse, and pin you all the families of the earth shall be blessed. Pray for the refreshment of the pastors and the ministry leaders who have been serving so faithfully in very hard times, and they're exhausted and they're going through grief.Pray for us as we minister to the ministers, and that God open financial doors. Related Episodes:Hamas Is Now Slaughtering Gazans — How Should Trump and Evangelicals Respond? #324Tal Heinrich - Inside Trump and Netanyahu’s Middle East #323Strength for Women & Families in a Time of War #322Ambassador Yechiel Leiter - Historic Gaza Hostage Deal #321 Donate a generous monthly gift to The Joshua Fund to bless Israel and Her Neighbors now and for the long haul. Become an Epicenter Ally today! Discover more Christian podcasts at lifeaudio.com and inquire about advertising opportunities at lifeaudio.com/contact-us.

Is the AI SOC analyst just hype, or is there measurable ROI? We spoke to Edward Wu, founder of Dropzone AI about this and he shared insights from a recent Cloud Security Alliance (CSA) benchmark report that quantified the impact of AI augmentation on SOC teams. The study revealed significant improvements in speed (45-60% faster investigations) and completeness, even for analysts using the tech for the first time.Edward spoke about the "robotic" limitations of traditional SOAR playbooks with the adaptive capabilities of agentic AI systems, which can autonomously investigate alerts end-to-end without pre-defined scripts . He shared that while AI won't entirely replace human analysts ("That's not going to happen"), it will automate much of the manual Tier 1 toil, freeing up humans for higher-value roles like security architecture, transformation, and detection engineering .Guest Socials -⁠ ⁠⁠⁠⁠⁠⁠Edward's Linkedin Podcast Twitter - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@CloudSecPod⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠If you want to watch videos of this LIVE STREAMED episode and past episodes - Check out our other Cloud Security Social Channels:-⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Cloud Security Podcast- Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠- ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Cloud Security Newsletter ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠- ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Cloud Security BootCamp⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠If you are interested in AI Cybersecurity, you can check out our sister podcast -⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ AI Security Podcast⁠Questions asked:(00:00) Introduction(02:40) Who is Edward Wu?(03:30) The Evolution of AI Agents Since ChatGPT(04:35) Surprising Findings from the CSA AI SOC Benchmark Report(06:40) Why Has Traditional Security Automation (SOAR) Underdelivered?(09:30) How AI SOC Analysts Differ from SOAR Playbooks(11:30) Does Agentic AI Reduce the Need for Security Data Lakes?(13:20) The Evolving ROI for SOC in the AI Era(14:50) ROI Use Case 1: Reducing Alert Investigation Latency(15:15) ROI Use Case 2: Increasing Alert Coverage (Mediums & Lows)(16:20) ROI Use Case 3: Depth of Coverage & Skill Uniformity(18:15) Achieving Both Speed and Thoroughness with AI(19:40) How Far Can AI Go? Detection vs. Investigation vs. Response(21:35) AI SOC Hype vs. Reality: Receptiveness and Trust(24:20) The Future Role of Tier 1 SOC Analysts(27:40) What Scale Benefits Most from AI SOC Analysts? (Enterprise & MSPs)(29:00) The Build vs. Buy Dilemma for AI SOC Technology ($20M R&D Reality)(33:10) Training Budgets: What Skills Should Future SOC Teams Learn?Resources spoken about during the episode:Beyond the Hype: AI Agents in the SOC Benchmark Study

A @Christadelphians Video:In this thought-provoking and insightful Milestones Bible Prophecy Update, we examine the future role of the Catholic Church in the unfolding of end-times events. Building on Part 1, this expositional presentation delves into Scripture to reveal how current Middle East dynamics and Vatican policies align with ancient prophecies concerning a final confederacy against Israel. We explore the significant shift in Vatican stance towards Israel and the Palestinians, the rise of 'Palestinian Liberation Theology', and the powerful symbolism in recent Papal visits. This analysis, presented by Brother Don Pearce, provides an outstanding look at how Bible prophecy is being outworked in our generation, pointing to the imminent return of the Lord Jesus Christ.**Chapters / Timestamps:**00:00 - Introduction00:50 - Preparing the Flock: A First-Century Warning02:03 - The Scattering of the Jews and the Rebirth of Israel03:00 - [Revealing] The Vatican as a Prophesied Enemy of Israel04:04 - The Papacy and the "Man of Sin"05:01 - Pope Francis and the Shift in Vatican Policy06:21 - Liberation Theology: Redefining Jesus and the Bible08:25 - Symbolism and Imagery: The Erasure of Jewish Heritage12:33 - The EU, The Church, and a United Power14:47 - Historical Papal Opposition to a Jewish Homeland15:35 - Daniel 2: The Prophetic Image and its Final Stage17:15 - Revelation 17: The Scarlet Woman and Babylon the Great20:13 - "Mother Church": The Titles and Claims of Rome21:51 - Pope Leo: A New Agenda and Vatican Finances24:54 - Revelation 18: The Merchants of the Earth25:22 - Conclusion**

We're joined by Pittsburgh Pirates pitching prospect Derek Diamond as he hits the road for his second stint in the Arizona Fall League. Derek opens up about his 2025 season, including the challenges of missing time with injury, his return to Altoona for a playoff push, and the adrenaline of being back on the mound. He talks about the transition from starter to bullpen, how he's building his pitch arsenal around a much-improved fastball, and why his changeup has become a true out pitch. We also dive into his AFL experiences—what it's like facing top prospects, learning a new role, and even starting the Fall League All-Star Game. Plus, Derek shares off-day favorites in Arizona, his love of golf, his offseason training goals, and a little Ole Miss vs. Georgia football trash talk. This is a fun and insightful conversation with one of the Pirates' most intriguing arms—don't miss it!

Send us a textMargins on Amazon are being squeezed as competition rises and ads dominate every listing. This video explains how ad saturation, FBA changes, and shifting strategies are shaping the seller experience. Sellers will learn what to expect as Amazon prioritizes paid ads, AI tools, and digital revenue streams.Stop letting ads drain your profits, book a call today to build a smarter Amazon ad strategy: https://bit.ly/4jMZtxu#AmazonAds #AmazonMargins #PayToPlay #AmazonSelling #ecommercetips Watch these videos on YouTube:Amazon PPC Tier List Management Rankings https://www.youtube.com/watch?v=m9s9vjtU5l4&list=PLDkvNlz8yl_a1PRDJWRoR4yIM8K5Ft569&utm_content=342357286&utm_medium=social&utm_source=youtube&hss_channel=ytc-UClUSEsDS2sdgNJfCcCM_5UwWhy Turning Off Ads Kills Sales and Rankings on Amazon: https://www.youtube.com/watch?v=fp5fCd0i7ts&list=PLDkvNlz8yl_a1PRDJWRoR4yIM8K5Ft569&index=2&utm_content=342357286&utm_medium=social&utm_source=youtube&hss_channel=ytc-UClUSEsDS2sdgNJfCcCM_5Uw-----------------------------------------------Tired of marketplace limits? Let's talk real growth with DTC strategy: https://bit.ly/4kOz6rrStop wasting ad spend. Grab the PPC guide that actually drives results: https://bit.ly/4lF0OYXRank higher and sell faster, get the SEO tools built for real growth: https://bit.ly/3JyMDGoBe ready before problems hit, download the kit every brand should have: https://bit.ly/4maWHn0Timestamps00:00 - Margins Squeezed and Pay-to-Play on Amazon00:18 - Amazon's Shift from AWS to Ads00:36 - Why FBA Prep Service Removal Matters01:07 - Ad Saturation: 1,032 Ads on a Single Listing01:37 - Competing for Visibility vs. DTC Websites02:54 - Why Sellers Must Maximize A+ Content03:56 - Remembering Cheap PPC Clicks from 10 Years Ago04:20 - Will Amazon PPC Costs Reach $40+ Per Click?04:39 - Why Walmart Isn't Competing with Amazon05:38 - The Future Role of AI in Online Shopping06:43 - Why Consumers Don't Trust AI Shopping Yet07:51 - Why AI Assistants Like Alexa Failed for Purchases08:13 - How AI Is Transforming Coding Instead08:22 - Why Regular Shoppers Won't Adopt AI Shopping Fast----------------------------------------------Follow us:LinkedIn: https://www.linkedin.com/company/28605816/Instagram: https://www.instagram.com/stevenpopemag/Pinterest: https://www.pinterest.com/myamazonguys/Twitter: https://twitter.com/myamazonguySubscribe to the My Amazon Guy podcast: https://podcast.myamazonguy.comApple Podcast: https://podcasts.apple.com/us/podcast/my-amazon-guy/id1501974229Spotify: https://open.spotify.com/show/4A5ASHGGfr6s4wWNQIqyVwSupport the show

Learn how to elevate Data Protection in the Age of AI with Ronan Murphy In this episode of CISO Tradecraft, host G Mark Hardy and guest Ronan Murphy, Chief Strategy Officer at Forcepoint, discuss the critical importance of data protection for enterprises in the age of AI. Discover expert insights on common mistakes CISOs make, how AI revolutionizes data security, and the evolving role of CISOs from enforcers to strategists. Learn about effective data governance, AI's impact on data, and leveraging tools like DLP & CASB for robust cybersecurity. Plus, hear about Forcepoint Aware 2025 and actionable strategies for elevating your organization's data security posture. https://www.forcepoint.com/aware Chapters 00:00 Introduction: The Importance of Data Security 00:26 Meet the Expert: Ronan Murphy's Background 02:40 Challenges in Data Protection 04:01 The Role of AI in Data Security 06:26 Strategies for Effective Data Management 19:05 Understanding Data Loss Prevention (DLP) 20:36 Exploring Cloud Access Security Brokers (CASB) 24:37 Data Security Posture Management (DSPM) 38:36 The Future Role of CISOs 40:30 Conclusion and Upcoming Events

Is your HR strategy stuck in the past while AI races ahead?

Dan Parkinson, founder of The Bitcoin IFA, shares an incredible journey from dismissing Bitcoin to building a business educating financial advisors about it.He recounts living through hyperinflation in Lebanon, the collapse of the Lebanese lira, and how his experience reshaped his view of money. Dan also discusses the challenges and opportunities for financial advisors in understanding Bitcoin, offering practical insights to bridge the gap between traditional finance and the Bitcoin future.00:00 - The Impact of Currency Devaluation in Lebanon13:55 - Transitioning from Financial Advisor to Bitcoin Advocate19:16 - Bridging Traditional Finance and Bitcoin27:15 - Navigating Regulatory Challenges in the Financial Sector32:04 - Challenges in Financial Advisory Training35:41 - Understanding Bitcoin: Overcoming Misconceptions40:07 - The Role of Continuous Professional Development (CPD)43:18 - Client Demand and Financial Advisors48:16 - The Future Role of Financial Advisors in a Bitcoin WorldFollow Dan:

Prof Marina Garassino, Dr John Heymach, Prof Solange Peters and moderator Dr Jacob Sands present key data from the ASCO 2025 Annual Meeting on the management of metastatic NSCLC without targetable mutations, as well as emerging evidence on the role of antibody-drug conjugates for patients with select actionable genomic alterations. CME information and select publications here.

Featuring perspectives from Prof Marina Chiara Garassino, Dr John V Heymach, Prof Solange Peters and Dr Jacob Sands, moderated by Dr Sands, including the following topics: Introduction (0:00) Role of Immune Checkpoint Inhibitors in Metastatic Non-Small Cell Lung Cancer (NSCLC) without a Targetable Tumor Mutation — Prof Peters (2:07) Targeted and Other Novel Therapeutic Strategies for Relapsed Metastatic NSCLC — Prof Garassino (26:30) Potential Role of TROP2-Targeted Antibody-Drug Conjugates in Advanced NSCLC — Dr Sands (50:19) Evolving Role of Immune Checkpoint Inhibitors in the Care of Patients with Nonmetastatic NSCLC — Dr Heymach (1:12:36) CME information and select publications

If you've heard that you'll get doughy trying to build muscle on beans, or indeed anything else that's made you doubt pulses even for a second, then this nugget's for you. Daisy and Clare discuss the nutrition of a range of legumes, as well as health benefits and environmental impacts, and how best to cook and eat them.Didinger, C.; Thompson, H.J. Defining Nutritional andFunctional Niches of Legumes: A Call for Clarity to Distinguish a Future Role for Pulses in the Dietary Guidelines for Americans. Nutrients 2021, 13,1100. https://doi.org/10.3390/nu13041100Mullins AP, Arjmandi BH. Health Benefits of Plant-BasedNutrition: Focus on Beans in Cardiometabolic Diseases. Nutrients. 2021 Feb5;13(2):519. doi: 10.3390/nu13020519. PMID: 33562498; PMCID: PMC7915747.

Featuring perspectives from Dr Virginia F Borges, Ms Jamie Carroll, Mr Ronald Stein and Dr Seth Wander, including the following topics: Introduction (0:00) Role of CDK4/6 Inhibitors in Localized and Metastatic Hormone Receptor (HR)-Positive Breast Cancer (12:49) PI3K Inhibition as First-Line Treatment for HR-Positive, HER2-Negative Metastatic Breast Cancer (mBC) (38:24) Clinical Utility of AKT and PI3K Inhibitors in Progressive HR-Positive mBC (1:01:44) Current and Future Role of Oral Selective Estrogen Receptor Degraders in HR-Positive mBC (1:24:38) NCPD information and select publications

Featuring perspectives from Dr Sunnie Kim, Ms Brooke Parker, Ms Michal Segal and Dr Manish Shah, including the following topics: Introduction: Clinical Presentation of Gastroesophageal Cancer (0:00) Management of Localized or Locally Advanced Gastroesophageal Cancers; Current and Future Role of Immune Checkpoint Inhibitors (21:44) Incorporation of Immunotherapeutic Strategies for HER2-Negative Metastatic Gastroesophageal Tumors (39:32) Role of Therapy Targeting CLDN18.2 in Advanced Gastric/Gastroesophageal Junction Adenocarcinoma (1:00:50) Considerations in the Care of Patients with HER2-Positive Gastroesophageal Cancers (1:22:41) NCPD information and select publications

Head on over to https://cell.ver.so/TOE and use coupon code TOE at checkout to save 15% on your first order. Get ready to witness a turning point in mathematical history: in this episode, we dive into the AI breakthroughs that stunned number theorists worldwide. Join us as Professor Yang-Hue Hi discusses the murmuration conjecture, shows how DeepMind, OpenAI, and EpochAI are rewriting the rules of pure math, and reveals what happens when machines start making research-level discoveries faster than any human could. AI is taking us beyond proof straight into the future of discovery. As a listener of TOE you can get a special 20% off discount to The Economist and all it has to offer! Visit https://www.economist.com/toe Join My New Substack (Personal Writings): https://curtjaimungal.substack.com Listen on Spotify: https://open.spotify.com/show/4gL14b92xAErofYQA7bU4e Timestamps: 00:00 Introduction to a New Paradigm 01:34 The Changing Landscape of Research 03:30 Categories of Machine Learning in Mathematics 06:53 Researchers: Birds vs. Hedgehogs 09:36 Personal Experiences with AI in Research 11:44 The Future Role of Academics 14:08 Presentation on the AI Mathematician 16:14 The Role of Intuition in Discovery 18:00 AI's Assistance in Vague Problem Solving 18:48 Newton and AI: A Historical Perspective 20:59 Literature Processing with AI 24:34 Acknowledging Modern Mathematicians 26:54 The Influence of Data on Mathematical Discovery 30:22 The Riemann Hypothesis and Its Implications 31:55 The BST Conjecture and Data Evolution 33:29 Collaborations and AI Limitations 36:04 The Future of Mathematics and AI 38:31 Image Processing and Mathematical Intuition 41:57 Visual Thinking in Mathematics 49:24 AI-Assisted Discovery in Mathematics 51:34 The Murmuration Conjecture and AI Interaction 57:05 Hierarchies of Difficulty 58:43 The Memoration Breakthrough 1:00:28 Understanding the BSD Conjecture 1:01:45 Diophantine Equations Explained 1:03:39 The Cubic Complexity 1:19:03 Neural Networks and Predictions 1:21:36 Breaking the Birch Test 1:24:44 The BSD Conjecture Clarified 1:26:21 The Role of AI in Discovery 1:30:29 The Memoration Phenomenon 1:32:59 PCA Analysis Insights 1:35:50 The Emergence of Memoration 1:38:35 Conjectures and AI's Role 1:41:29 Generalizing Biases in Mathematics 1:44:55 The Future of AI in Mathematics 1:49:28 The Brave New World of Discovery Links Mentioned: - Topology and Physics (book): https://amzn.to/3ZoneEn - Machine Learning in Pure Mathematics and Theoretical Physics (book): https://amzn.to/4k8SXC6 - The Calabi-Yau Landscape (book): https://amzn.to/43DO7H0 - Yang-Hui's bio and published papers: https://www.researchgate.net/profile/Yang-Hui-He - A Triumvirate of AI-Driven Theoretical Discovery (paper): https://arxiv.org/abs/2405.19973 - Edward Frenkel explains the Geometric Langlands Correspondence on TOE: https://www.youtube.com/watch?v=RX1tZv_Nv4Y - Stone Duality (Wiki): https://en.wikipedia.org/wiki/Stone_duality - Summer of Math Exposition: https://some.3b1b.co/ - Machine Learning meets Number Theory: The Data Science of Birch–Swinnerton-Dyer (paper): https://arxiv.org/pdf/1911.02008 - The L-functions and modular forms database: https://www.lmfdb.org/ - Epoch AI FrontierMath: https://epoch.ai/frontiermath/the-benchmark - Mathematical Beauty (article): https://www.quantamagazine.org/mathematical-beauty-truth-and-proof-in-the-age-of-ai-20250430/ SUPPORT: - Become a YouTube Member (Early Access Videos): https://www.youtube.com/channel/UCdWIQh9DGG6uhJk8eyIFl1w/join - Support me on Patreon: https://patreon.com/curtjaimungal - Support me on Crypto: https://commerce.coinbase.com/checkout/de803625-87d3-4300-ab6d-85d4258834a9 - Support me on PayPal: https://www.paypal.com/donate?hosted_button_id=XUBHNMFXUX5S4 SOCIALS: - Twitter: https://twitter.com/TOEwithCurt - Discord Invite: https://discord.com/invite/kBcnfNVwqs #science Learn more about your ad choices. Visit megaphone.fm/adchoices

Featuring perspectives from Dr Rahul Aggarwal, Ms Monica Averia, Ms Kathleen D Burns and Dr William K Oh, including the following topics: Introduction: Overview of Prostate Cancer (0:00) Recent Advances in the Treatment of Nonmetastatic Prostate Cancer (8:36) Treatment Approaches for Metastatic Hormone-Sensitive Prostate Cancer (30:01) Current Role of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (47:41) Current and Future Role of Radiopharmaceuticals in mCRPC (1:09:57) NCPD information and select publications

Analyzing Andrew Van Ginkel's Contract Extension & Tai Felton's Future Role with the Vikings—In this episode of The Real Forno Show, host Tyler Forness and producer Dave Stefano delve into the implications of Andrew Van Ginkel's contract extension for the Minnesota Vikings and what it means for Dallas Turner's role on the team. They provide detailed insights into the Vikings' draft choices, including Donovan Jackson and Tai Felton, as well as discuss the strengths and weaknesses of these new players. Tyler breaks down how the Vikings' defensive strategies might evolve and what fans can expect from the edge rusher depth chart. The episode also features a lively interaction with viewers, touching on various topics like the state of Minnesota sports, J.J. McCarthy's impressive leadership, and which recently drafted Minnesota Gopher might have the best NFL career. This comprehensive review is perfect for Vikings fans looking to understand the team's prospects and future. Join us for another episode brought to you by Fans First Sports Network. 00:00 Introduction and Show Overview 01:30 Minnesota Vikings Draft Recap 02:00 Andrew Van Ginkel Extension Analysis 04:18 Edge Rusher Depth and Strategy 09:27 Dallas Turner's Role and Potential 15:14 Viewer Questions and Interaction 22:58 Closing Remarks and Shoutouts 26:05 Teaching Marzipan to Be a Dog 26:28 Introducing Tai Felton: New Weapon for J.J. McCarthy 27:01 Strengths and Weaknesses of Tai Felton 29:13 Concerns About Felton's Agility and Route Running 31:19 Potential and Development of Tai Felton 41:04 J.J. McCarthy's Press Conference and Vikings' Power Rankings 43:23 Minnesota Sports and Draft Picks Discussion 46:14 Wrapping Up and Future Plans FAN WITH US!!! Tyler Forness @TheRealForno of Vikings 1st & SKOL @Vikings1stSKOL and A to Z Sports @AtoZSportsNFL and Dave Stefano @Luft_Krigare producing this Vikings 1st & SKOL production, on the @RealFornoShow. Podcasts partnered with Fans First Sports Network @FansFirstSN and Fans First Sports Network's NFL feed @FFSN_NFL. ____________________________________________________________ ⭐️ Subscribe to us here! - https://www.youtube.com/@vikings1stskol92 ⭐️ Our Twitter can be found at @Vikings1stSKOL ⭐️ Tyler Forness can be read at A to Z Sports - https://atozsports.com/nfl/minnesota-vikings-news/ ⭐️ At Fans First Sports Network - https://www.ffsn.app/teams/minnesota-vikings/ ⭐️ On Facebook - https://www.facebook.com/vikings1standskol ⭐️ Watch the live show here: https://youtu.be/-xoKAKMvaN0 Learn more about your ad choices. Visit megaphone.fm/adchoices

Featuring perspectives from Ms Courtney Arn, Ms Jennifer Filipi, Dr David M O'Malley and Dr Shannon N Westin, including the following topics: Introduction: Overview of Ovarian Cancer (OC) Management (0:00) Genetic Testing for Newly Diagnosed Advanced OC (14:31) Role of PARP Inhibitor Maintenance in Newly Diagnosed Advanced OC (22:46) Other Available and Investigational Novel Strategies for OC (43:56) Current and Future Role of Mirvetuximab Soravtansine in OC Treatment (1:19:24) NCPD information and select publications

#updateai #customersuccess #saas #businessJosh Schachter, Co-Founder & CEO of UpdateAI, sits down with Carly Van Kirk, Head of CS at AngelList. Carly pulls back the curtain on AngelList's unique approach to supporting emerging and established GPs and shares her journey into this pivotal leadership role amidst rapid company growth and industry transformation. Join us as Carly shares how AngelList is reshaping customer segments, dealing with the challenges of scaling an increasingly complex platform, and balancing high-touch professional services with tech-driven solutions.Timestamps0:00 - Preview1:45 - Overview of AngelList2:35 - COVID-Era Growth & Rolling Fund at AngelList4:12 - Carly's Role, Team Structure & Customer Segmentation at AngelList9:30 - Hunting for a New Job13:20 - Carly's Priorities in Her First 180 Days at AngelList14:45 - Key Challenges and Initiatives Identified14:45 - Automation, Tooling, and Workflow Inefficiencies22:43 - Understanding and Improving Time to Value24:24 - AI's Current and Future Role in AngelList and CS27:36 - Customer Success as a Commercial Center___________________________

In This EpisodeWe are speaking with Nada Ahmed and Jason Ethier, two of the founding partners at Energy Tech Nexus. Energy Tech Nexus is a Houston-based hub designed to connect EnergyTech startups with the resources they need to grow. This includes access to capital, corporate partners, direct access to pilot opportunities, as well as a community of other founders doing the same thing. In this episode, we dive into **how they're building an innovation powerhouse in the heart of the U.S. energy industry, **the evolving role of oil majors in clean tech, **and how to navigate the new regulatory landscape of the Trump administration ---

International law enforcement takes down a pair of notorious hacking forums. Wiz discovers an open DeepSeek database. Time Bandit jailbreaks ChatGPT. Ransomware hits one of the largest U.S. blood centers. A cyberattack takes the South African Weather Service offline. Researchers describe a new “browser syncjacking” attack. TeamViewer patches a high-severity privilege escalation flaw. Over three dozen industry groups urge Congress to pass a national data privacy law. CISA faces an uncertain future. N2K's Brandon Karpf speaks with Ellen Chang, Vice President Ventures at BMNT and Head of H4XLabs. OpenAI Cries Foul After Getting a Taste of Its Own Medicine.  Remember to leave us a 5-star rating and review in your favorite podcast app. Miss an episode? Sign-up for our daily intelligence roundup, Daily Briefing, and you'll never miss a beat. And be sure to follow CyberWire Daily on LinkedIn. CyberWire Guest Today, N2K's Brandon Karpf speaks with Ellen Chang, Vice President Ventures at BMNT and Head of H4XLabs, about the venture model, why it exists, how it works, and its impact. Selected Reading Police seizes Cracked and Nulled hacking forum servers, arrests suspects (Bleeping Computer) Wiz Research Uncovers Exposed DeepSeek Database Leaking Sensitive Information, Including Chat History (Wiz) Time Bandit ChatGPT jailbreak bypasses safeguards on sensitive topics(Bleeping Computer) US blood donation giant warns of disruption after ransomware attack (TechCrunch) South Africa's government-run weather service knocked offline by cyberattack (The Record) Syncjacking Attack Enables Full Browser and Device Takeover (Infosecurity Magazine) TeamViewer Patches High-Severity Vulnerability in Windows Applications (SecurityWeek) Industry groups call on Congress to enact federal data privacy law (The Record) US Cyber Agency's Future Role in Elections Remains Murky Under the Trump Administration (SecurityWeek) OpenAI Furious DeepSeek Might Have Stolen All the Data OpenAI Stole From Us (404 Media) Share your feedback. We want to ensure that you are getting the most out of the podcast. Please take a few minutes to share your thoughts with us by completing our brief listener survey as we continually work to improve the show.  Want to hear your company in the show? You too can reach the most influential leaders and operators in the industry. Here's our media kit. Contact us at cyberwire@n2k.com to request more info. The CyberWire is a production of N2K Networks, your source for strategic workforce intelligence. © N2K Networks, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us a textBennett Sung, Strategic Marketing Advisor at Restworld and Fractional CMO at MeBeBot, joins us in this episode to explore AI's current and future role in HR. He talks about where AI best fits within existing HR tech stacks and shares exciting prospects for AI implementation, while also considering how pay transparency is transforming recruitment strategies.This conversation took place at the HR Tech 2024 conference in Las Vegas. [0:00] IntroductionWelcome, Bennett!Today's Topic: Exciting Prospects for AI Implementation[7:36] How will AI fit into existing HR technology stacks?HR's evolving relationship with finance may include learning to “follow the money”The increasing intersection of HR and IT through new data governance requirements[15:51] Will pay transparency be a game changer for recruitment?Leveraging total compensation statements as strategic recruitment tools[21:31] Will 2025 be a breakthrough year for AI in HR?Financial investment enabling HR to “do more with less” through AIThe importance of succession planning as baby boomers exit the workforceThe emerging potential of AI agents[39:45] ClosingThanks for listening!Quick Quote“Following the money is important for HR to master . . . to build business cases for the long term.”Contact:Bennett's LinkedInDavid's LinkedInDwight's LinkedInPodcast Manager: Karissa HarrisEmail us!Production by Affogato Media

David Gornoski sits down with Dr Robert W Malone for a conversation on a possible role in Trump's administration, whether he would help Elon Musk cut government, why Trump must listen to dissidents against Big Pharma, who can help turn the health sector around, the legacy of Ron Paul, and more. Check out Robert W Malone's Substack here. Follow David Gornoski on X here. Visit aneighborschoice.com for more

Guy Podjarny founded Tessl, Snyk and Blaze. Tessl is reimagining software development for the AI era and shaping AI Native Development. Snyk created and leads the Developer Security category, and is now a multi-billion dollar company with over 1,000 employees. Guy was previously CTO at Akamai (following its acquisition of Blaze), is an active angel investor, and co-hosts of the AI Native Dev podcast. In Today's Episode with Guy Podjarny We Discuss:  03:02 Discussion on NVIDIA's Market Position 04:14 Will We See a Trough of Disillusionment in AI 07:36 The Future of AI Development and Specialized Models 10:17 Challenges and Opportunities in AI Dev Tools 17:41 Concerns About Closed vs. Open Development Platforms 21:27 Speculations on AI's Role in Application Layers 24:40 Google's Competitive Edge 25:28 IPO and M&A in the Trump Era 26:45 The Future Role of Software Developers 32:20 Security Challenges in AI Development 33:41 Spicy Questions and Charity Donations 36:05 Quickfire Round: Insights and Advice      

In this episode, the conversation revolves around the role of professional bodies in project management, particularly focusing on the APM (Association for Project Management). Adam Boddison, the CEO of APM, discusses the importance of community engagement, the challenges faced by the project management profession, and the impact of AI on the industry. The discussion also touches on career development, the need for a unified approach among professional bodies, and the future of project management in a rapidly changing technological landscape. Takeaways Project management is often misunderstood and needs better representation. Community engagement is crucial for career development in project management. AI will play a significant role in the future of project management. Professional bodies like APM are essential for supporting project professionals. The definition of project success varies and needs to be clarified. There is a shortage of qualified project professionals globally. Project management should focus on people, not just processes. The APM aims to inspire communities to deliver meaningful change. Collaboration among professional bodies can benefit the project management profession. AI literacy is becoming increasingly important for project professionals. Chapters 00:00 Introduction and Welcome 04:56 Adam's Journey into Project Management 06:20 Defining Project Management 08:40 The Role of APM and its Mission 09:55 Expanding APM's Global Footprint 14:49 Choosing a Professional Body for Career Development 17:53 Engagement with Professional Bodies 23:08 Differentiators of APM 27:08 Shortage of Project Professionals 31:50 Addressing the PR Problem in Project Management 36:17 Project Success and Challenges 42:58 Introduction and Discussion on Major Infrastructure Projects 44:05 The Role of APM and Other Associations in Major Projects 46:56 AI in the Body of Knowledge and the Challenge of Keeping Up 49:30 Collaboration with Government Organizations for Project Assurance 52:58 The Focus on Project Controls in APM 57:13 The Importance of Data and AI Literacy for Project Professionals 01:03:09 The Impact of AI on Project Managers and Project Management Skills 01:09:45 The Future Role of AI as Personal Assistants for Project Professionals 01:14:21 Five Quickfire Questions 01:17:28 Final Thoughts and Encouragement to Join the Project Management Profession 01:18:55 Outtro template A.mp3 Proudly sponsored by⁠ Deltek

Scott and Moe answer your mailbag questions post-Week 11 and talk about what Tom Brady can bring to the organization. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Gabe of Libre Solutions Network and Mathew Crawford discuss all things bitcoin and how it seems the plan was to have Trump installed and push crypto. They comment on the role of the U.S. military, influencers, BlackRock, the potential future role of bitcoin erasing U.S. debt and functioning as a banking currency, digital gold, tulip mania, viewing the technology as neutral, bitcoin's future price, and more! Watch on BitChute / Brighteon / Rokfin / Rumble / Substack Geopolitics & Empire · Gabe (LSN) & Mathew Crawford: Bitcoin's Rise & It's Future Role...Tulip Mania or Digital Gold? #491 *Support Geopolitics & Empire! Donate https://geopoliticsandempire.com/donations Consult https://geopoliticsandempire.com/consultation Become a Member https://geopoliticsandempire.substack.com Become a Sponsor https://geopoliticsandempire.com/sponsors **Visit Our Affiliates & Sponsors! Above Phone https://abovephone.com/?above=geopolitics easyDNS (use code GEOPOLITICS for 15% off!) https://easydns.com Escape The Technocracy course (15% discount using link) https://escapethetechnocracy.com/geopolitics LegalShield https://hhrvojemoric.wearelegalshield.com Sociatates Civis (CitizenHR, CitizenIT, CitizenPL) https://societates-civis.com Wise Wolf Gold https://www.wolfpack.gold/?ref=geopolitics Gabe (Libre Solutions) Websites Libre Solutions Network https://libresolutions.network Libre Solutions Substack https://libresolutionsnetwork.substack.com About Gabe (Libre Solutions) Gabe is working to share and teach the tools and tactics needed to oppose digital tyranny by encouraging others to start their journey in building up their own digital autonomy. Mathew Crawford Websites Substack https://roundingtheearth.substack.com X https://x.com/EduEngineer About Mathew Crawford Mathew Crawford is an Educator, Entrepreneur, Statistician, Finance Specialist, and Founder of Rounding the Earth. *Podcast intro music is from the song "The Queens Jig" by "Musicke & Mirth" from their album "Music for Two Lyra Viols": http://musicke-mirth.de/en/recordings.html (available on iTunes or Amazon)

Gabe of Libre Solutions Network and Mathew Crawford discuss all things bitcoin and how it seems the plan was to have Trump installed and push crypto. They comment on the role of the U.S. military, influencers, BlackRock, the potential future role of bitcoin erasing U.S. debt and functioning as a banking currency, digital gold, tulip mania, viewing the technology as neutral, bitcoin's future price, and more! Watch on BitChute / Brighteon / Rokfin / Rumble / Substack Geopolitics & Empire · Gabe (LSN) & Mathew Crawford: Bitcoin's Rise & It's Future Role...Tulip Mania or Digital Gold? #491 *Support Geopolitics & Empire! Donate https://geopoliticsandempire.com/donations Consult https://geopoliticsandempire.com/consultation Become a Member https://geopoliticsandempire.substack.com Become a Sponsor https://geopoliticsandempire.com/sponsors **Visit Our Affiliates & Sponsors! Above Phone https://abovephone.com/?above=geopolitics easyDNS (use code GEOPOLITICS for 15% off!) https://easydns.com Escape The Technocracy course (15% discount using link) https://escapethetechnocracy.com/geopolitics LegalShield https://hhrvojemoric.wearelegalshield.com Sociatates Civis (CitizenHR, CitizenIT, CitizenPL) https://societates-civis.com Wise Wolf Gold https://www.wolfpack.gold/?ref=geopolitics Gabe (Libre Solutions) Websites Libre Solutions Network https://libresolutions.network Libre Solutions Substack https://libresolutionsnetwork.substack.com About Gabe (Libre Solutions) Gabe is working to share and teach the tools and tactics needed to oppose digital tyranny by encouraging others to start their journey in building up their own digital autonomy. Mathew Crawford Websites Substack https://roundingtheearth.substack.com X https://x.com/EduEngineer About Mathew Crawford Mathew Crawford is an Educator, Entrepreneur, Statistician, Finance Specialist, and Founder of Rounding the Earth. *Podcast intro music is from the song "The Queens Jig" by "Musicke & Mirth" from their album "Music for Two Lyra Viols": http://musicke-mirth.de/en/recordings.html (available on iTunes or Amazon)

Featuring an interview with Dr Gilles Salles, including the following topics: Epigenetic modifications and the role of EZH2 in the pathobiology of follicular lymphoma (FL) (0:00) Natural history of FL and current treatment landscape in the first-line setting (5:20) Testing approaches for the detection of EZH2 mutations (14:37) Mechanism of action of the EZH inhibitors tazemetostat and valemetostat (18:31) Tazemetostat monotherapy as treatment for relapsed/refractory FL (20:58) Ongoing evaluation of novel treatment approaches with tazemetostat for FL and other lymphomas (25:31) Approved indications for tazemetostat for wild-type FL and FL with EZH2 mutations; sequencing of tazemetostat with bispecific antibodies and CAR T-cell therapy (34:07) Available clinical data with the novel dual EZH1/EZH2 inhibitor valemetostat (42:37) Personal experience with CAR T-cell therapy and perspectives on possible underlying reasons for the development of T-cell lymphoma in patients receiving this treatment (44:35) Management of FL in patients who experience relapse within 24 months of receiving treatment (POD24) (48:25) Myths or misperceptions associated with tazemetostat and other therapies approved in the relapsed FL setting (52:15) Perspectives on the future treatment landscape of FL (54:29) CME information and select publications

What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma — Gilles Salles, MD, PhD CME information and select publications

Dr Gilles Salles from the Memorial Sloan Kettering Cancer Center in New York, New York, reviews current and novel EZH1/2 inhibitor-based treatment strategies for follicular lymphoma, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/WCWtK2024/EZH2Lymphoma).

Dr Gilles Salles from the Memorial Sloan Kettering Cancer Center in New York, New York, reviews current and novel EZH1/2 inhibitor-based treatment strategies for follicular lymphoma.

Welcome to another episode of Pearls On, Gloves Off with your host, Mary O'Carroll, Chief Operating Officer at Goodwin. In this episode, Mary sits down with Reena SenGupta, a longtime analyst, writer, consultant, and thought leader in the global legal industry with almost 30 years of experience. Reena's journey is impressive. She is an entrepreneur and journalist who has developed some of the most influential rankings and programs in the legal world. She was instrumental in creating the Chambers and Partners Guides in the mid-90s and the Financial Times Innovative Lawyers Program, which is about to celebrate its 20th anniversary. In 2001, Reena founded RSG Consulting, which quickly became a leading brand in the legal sector. Today, she heads up RSGI, a global think tank focused on building a sustainable future for the legal industry. Reena is also a seasoned public speaker and regular contributor to the Financial Times, always bringing fresh, forward-thinking perspectives to the table. In this episode: ·         The Changing Legal Landscape: Exploring how the legal industry has evolved over the past two decades, including shifts in mindset and practice. ·         Defining Innovation in Law: Discussing what innovation truly means in the legal context and how it's being implemented in firms and legal departments. ·         The Impact of Generative AI: Examining how generative AI is transforming legal work, from automating routine tasks to enabling lawyers to focus on strategic, high-value activities. ·         The Future Role of Lawyers: Insights into what the lawyer of tomorrow looks like, including the skills and roles that will be essential in a changing industry. ·         Client Expectations and Pressures: Understanding what's driving client expectations and how law firms can better meet their clients' evolving needs. ·         Challenges and Opportunities: Addressing the obstacles holding back the industry and the exciting opportunities for growth and transformation. ·         Reena's Predictions: Reena shares her predictions for the next 12 months and beyond, including the potential for law firms to become masters of their own data. If you enjoyed our conversation with Reena SenGupta, be sure to subscribe to Pearls On, Gloves Off for more candid discussions with leaders shaping the legal and corporate landscape. We'd love to hear your thoughts—connect with us on social media and join the conversation! Follow Mary on LinkedIn Rate and review on Apple Podcasts  

Take us on those Country Roads! We are available on Apple, Spotify, YouTube & wherever else you get your podcasts. Apple: https://podcasts.apple.com/us/podcast/the-ryan-and-rush-show/id1604428144Spotify: https://open.spotify.com/show/3cWNA21qFJG1YLrUbwM0UI?si=d93b3e30b6b24429Youtube: https://www.youtube.com/channel/UC8AjkTBBo7G7vG1cqjszhUAYou can also find us at RyanandRush.com! Donate Here: https://www.paypal.com/donate/?hosted_button_id=2XSRNBQB6XREAVenmo: @ryanandrushshowFollow Ryan & Rush on X/Twitter & Instagram: @Ryanandrushshow  @ramblingrush @moneyline_Mac

Taylor Riggs, Co-anchor of the "The Big Money Show" joins Marc & Kim to talk about how polls affect Wall Street, the boycott called for against Kelloggs, and where'd she'd like to see RFK JR, in the FDA or the CIA.

Jacob and Nikhil sit down with Parth Mehrotra, CEO of Privia Health. Privia is a physician enablement platform partnering with 4500+ providers towards practice improvement and value-based care. They discuss the most important ways to manage risk, building effective physician enablement solutions, the future of value-based care programs & contracts, and more. [0:00] Intro[0:55] Privia's Business Model and Footprint[3:26] Physician Choices and Privia's Role[6:06] Evolution of Value-Based Care[8:42] Future Role of Payers in Healthcare[10:48] Choosing Geographic Markets for Expansion[11:53] Physician Enablement Market Dynamics[15:02] Influencing Practice Processes Without Ownership[18:52] Evaluating Value-Based Programs[21:47] Capabilities Needed for Risk-Based Contracts[24:28] Risk Pooling and Healthcare Economics[28:31] Future of Value-Based Care[31:40] Primary Care and Specialist Roles[36:18] Commercial vs. Medicare Value-Based Care[39:30] AI in Healthcare: Current and Future Applications[43:02] Quickfire Out-Of-Pocket: https://www.outofpocket.health/

Pre-Season wrap up + Our Knicks season predictions! Follow the KnicksNation Socials!YouTubeXInstagram

Nicole Leffer, an AI advisor to CMOs, shares her journey and insights on AI in marketing. She started an e-commerce company in college and grew it to be one of the top 1,000 internet retail companies in the country. After discovering AI writing tools, she saw the immense impact it had on marketing productivity and quality. Nicole now works with companies to implement AI in their marketing strategies and offers a course on generative AI for B2B marketing. She discusses how AI is revolutionizing content creation, idea generation, and strategy development in marketing. She also predicts that CMOs will become AI orchestrators, leveraging AI tools to control and optimize marketing efforts. The conversation explores the misconceptions and opportunities surrounding AI in marketing. Nicole Leffer emphasizes the need for more people to learn and understand AI, as there is a tremendous opportunity for growth and differentiation. She discusses how AI can improve efficiency and quality, but cautions against relying too heavily on automation without human oversight. The conversation also touches on the future of AI in marketing, including smarter tools, improved natural conversation, and the potential for AI to understand and analyze videos. Nicole offers training and advisory services to help marketers leverage AI effectively. Takeaways AI is transforming content creation and marketing strategy, allowing for faster and more efficient processes. CMOs need to upskill their teams and hire individuals with AI skills to implement and leverage AI tools effectively. The role of the CMO will evolve to become an AI orchestrator, controlling and optimizing marketing efforts with the help of AI. Start with a core AI tool, such as ChatGPT or Claude, and master its features and communication techniques before exploring additional tools. AI can be used for idea generation, content optimization, and strategic planning, providing valuable insights and expertise. There is a significant opportunity for marketers to learn and understand AI to differentiate themselves and take advantage of its capabilities. AI can improve efficiency and quality, allowing marketers to accomplish more in less time. It is important to strike a balance between automation and human oversight to ensure the best results. The future of AI in marketing includes smarter tools, improved natural conversation, and the ability to analyze videos. Nicole Leffer offers training and advisory services to help marketers effectively leverage AI. Chapters 00:00 Introduction and Background 02:44 The Impact of AI on Marketing 06:34 Working with Companies and Evolving with AI 09:13 AI in Content Creation and Strategy 13:49 The Future Role of CMOs 18:26 Getting Started with AI in Marketing 22:34 The Tremendous Opportunity in AI 26:11 Achieving Incredible Results with AI 29:24 Personalization and Efficiency with AI 32:42 The Future of AI in Marketing 36:18 Training and Advisory Services for AI in Marketing

Featuring perspectives from Dr Joshua Brody, Dr Ian W Flinn and Dr Tycel Phillips, including the following topics: Introduction: CD3 Bispecific Antibodies in the Community Oncology Setting (0:00) Integration of Bispecific Antibody Therapy into the Management of Diffuse Large B-Cell Lymphoma — Dr Phillips (18:13) Current and Future Role of Bispecific Antibodies in Follicular Lymphoma and Other B-Cell Lymphomas — Dr Flinn (41:20) Tolerability and Other Practical Considerations with the Use of Bispecific Antibody Therapy — Dr Brody(50:49) CME information and select publications

Episode Title: How AI is Disrupting Sales and Marketing with Raj Prasad Episode Description: In this episode of The Silicon Valley Podcast, our host dives deep into the world of AI in marketing with expert Raj Prasad. With over 25 years of marketing experience, including roles as a CEO and Fractional CMO, Raj has developed a deep understanding of brand development and revenue growth. Join us as Raj shares insights from his impressive career and explores the transformative impact of AI on marketing strategies. From search engine optimization to targeted advertising, learn how AI is revolutionizing the way marketers understand consumer behavior and optimize their campaigns. Whether you're a small business owner or a seasoned marketer, this episode is packed with valuable advice on integrating AI into your marketing efforts. Key Questions and Topics: Career Journey: Raj, can you tell our audience a little bit about your career up to this point? AI in Marketing Applications: What are some specific applications of AI in marketing that you find most impactful? SEO and Content Optimization: Can you discuss the impact of AI on search engine optimization (SEO) and content optimization? Consumer Behavior Analysis: How has AI changed the way marketers understand and analyze consumer behavior? Revolutionary AI Tools: Can you share examples of AI-powered tools or platforms that have revolutionized marketing strategies? Future of Targeted Advertising: How do you see AI shaping the future of targeted advertising and audience segmentation? Campaign Performance and ROI: In what ways does AI contribute to improving marketing campaign performance and ROI? Social Media Marketing: How can marketers leverage AI to optimize their social media marketing efforts? Challenges and Limitations: What challenges or limitations do marketers face when implementing AI in their strategies? AI for Small Businesses: How can small businesses or startups with limited resources benefit from AI in their marketing efforts? Future Role of Marketers: How do you see AI influencing the role of marketers in the future? Advice for Marketers: What advice would you give to marketers who are considering integrating AI into their marketing strategies? About Raj Prasad: Raj Prasad has over 25 years of marketing experience, including roles as a CEO and Fractional CMO. He has developed a deep understanding of brand development and revenue growth, focusing on using a range of marketing tools, such as PPC, SEO, Influencer Marketing, and Event Marketing, to build and strengthen brands. A key achievement was leading the product management for an Online Franchise Dealer Portal, an innovative B2B subscription model, which generated $24 million in revenue over four years. His approach centers around implementing effective digital marketing strategies, contributing to enhanced brand recognition and business performance. This experience is well-suited for roles requiring a strategic yet hands-on approach to digital marketing, where data-driven decisions and a clear vision are essential for driving growth. Connect with Raj Prasad:https://www.linkedin.com/in/rajpras/ Raj Prasad | LinkedIn   Listen Now: Tune in to this insightful conversation with Raj Prasad and discover how AI can transform your marketing strategies for better performance and results. Make sure to subscribe to The Silicon Valley Podcast for more expert insights and discussions on the latest trends in technology and business. Don't forget to leave us a review and share this episode with your network!

Send Everyday AI and Jordan a text messageIf you think content writing is the only way to use AI for SEO, think again. That's just the beginning. AI is changing SEO as we know it. We have SEO expert Steve Toth give us the scoop on how to *actually* leverage AI for SEO that's more than just vanilla blog posts.Newsletter: Sign up for our free daily newsletterMore on this Episode: Episode PageJoin the discussion: Ask Jordan and Steve questions on AI and SEORelated Episodes:Ep 191: AI Search Takeover – The End of Traditional SEO + Web Browsing?Ep 137: Writers and Content Creators' Future Role in a World of AIUpcoming Episodes: Check out the upcoming Everyday AI Livestream lineupWebsite: YourEverydayAI.comEmail The Show: info@youreverydayai.comConnect with Jordan on LinkedInTopics Covered in This Episode:1. Utilizing AI for SEO beyond content writing2. Human-written content with AI enhancements for SEO3. Role of Google in content quality control4.  Pros and cons of AI content5. Practical applications of AI in content creationTimestamps: 01:20 Daily AI news04:14 About Steve and SEO Notebook05:45 Ways to leverage AI for SEO08:14 Hybrid AI content okay, mass AI content dangerous.11:58 Links from authoritative sites boost website credibility.15:30 Human input essential in Google's data analysis.19:16 Predicting SEO's future, Google controls web traffic.21:57 AI prefers comprehensive, well-researched content with links.26:35 Tips on improving call to action with AI.28:48 Use AI to enhance and polish your content.Keywords:SEO, Steve Toth, AI tools for SEO, open API, Python, Google.com, keyword research, auto suggest results, related searches, People Also Ask, call to action, AI content enhancement, topics for comprehensive guide, Jordan Wilson, free daily newsletter, everydayai.com, prime prompt polish chat GPT course, podpp.com, unpredictability of SEO, Google's control over web traffic, AI-generated content, B2B SaaS content, Google's SGE, OpenAI partnership deals, Reddit, Stack Overflow, organic web traffic, SERPs, SEO Notebook, FreshBooks Get more out of ChatGPT by learning our PPP method in this live, interactive and free training! Sign up now: https://youreverydayai.com/ppp-registration/

Do you like your electronic collars? Your tracking collars? Do you think its right for houndsmen to be prevented from chasing mountain lions and bobcats? Do you think its silly to have the public vote on a measure that would outlaw lynx hunting even though they're already on the endangered species list and therefore its already illegal to hunt them? Brace yourselves as this episode we jump on the soap box and we stay there! Chris Powell of the Houndsman XP joins me to catch us up on what is happening in Colorado as it pertains to Initiative 91 and what that means for hunters regardless of your game of choice and why it matters even though you don't live there. Chris and I have a very open conversation on where each of us thinks the hunting community/culture currently is and how we can stop standing on our heels and start taking the fight to the other side. We are always on defense and reacting. Its time for all hunters to take charge. We aren't fur hunters or bird hunters. We are hunters! Death by a 1,000 cuts over decades. This didn't happen overnight. Does the term "science" mean anything anymore? Lead from where you are The nonprofit organizations are built to sustain us but not fight for us! We don't want to be talking about this anymore than you want to be hearing about this We inherited this. What are we passing on? Links discussed in the episode: Coloradans for Responsible Wildlife Management Houndsman XP Episode: Battleground 2024 February Update Colorado's Wildlife Deserve Better Randy Newberg's Future Role of Hunters and Hunting (Part 1 of 4) - GDIY Links: Patreon | Instagram | Facebook | Website Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode (#230) of Leupold's Hunt Talk Radio, Randy is joined by Andrew McKean for the first of four episodes regarding attacks on hunting and wildlife management. This episode lays out what has been happening in Washington and Colorado, exploring how/why it is happening, what the consequences will be, and how hunters are responding. For many, actions in these states represent one of the greatest threats, and possible opportunities, to the role hunting and hunters will play in wildlife management. Learn more about your ad choices. Visit megaphone.fm/adchoices